Fibroblast activation protein α-positive pancreatic stellate cells promote the migration and invasion of pancreatic cancer by CXCL1-mediated Akt phosphorylation.

Background Pancreatic stellate cells (PSCs) is a highly heterogeneic stroma cell population in pancreatic cancer tissue. Interaction between PSCs and pancreatic cancer cells has not been well elucidated. This research was aimed to study the relationship between fibroblast activation protein α (FAPα)-positive (FAPα+) PSCs and the pathological features and prognosis of pancreatic cancer. The effects and mechanisms of FAPα + PSCs in pancreatic cancer were also explored. Methods Tissue microarray analysis was used to detect FAPα expression in tumor and adjacent tissues. The relationship between FAPα expression and pancreatic pathological features and prognosis were analyzed. The effects of FAPα+ PSCs on the proliferation, migration and invasion of pancreatic cancer were detected in vitro and in vivo. A cytokine chip was used to detect the differential expression of cytokines in FAPα-positive (FAPα+) and FAPα-negative (FAPα-) PSCs. Phosphorylated tyrosine kinase receptors were detected by a human phosphotyrosine kinase receptor protein chip. The interaction between differential cytokine and tyrosine kinase receptors was detected by immunoprecipitation. Results Compared with the adjacent tissues, pancreatic cancer stromal tissues showed high FAPα expression. FAPα was mainly expressed in the PSCs. FAPα+ PSCs were associated with lymph node metastasis. Higher numbers of FAPα+ PSCs predicted shorter survival. Pancreatic cancer cells released TGFβ1 and induced PSCs to express FAPα. FAPα+ PSCs released the chemokine CXCL1 and promoted the phosphorylation of the tyrosine kinase receptors EphB1 and EphB3 in pancreatic cancer cells. CXCL1, EphrinB1, and EphrinB3 worked together to promote the migration and invasion of pancreatic cancer cells by Akt phosphorylation. Talabostat (PT100), an FAPα inhibitor, inhibited the roles of FAPα+ PSCs. Conclusions FAPα+ PSCs can promote the migration, invasion, and metastasis of pancreatic cancer by the Akt signaling pathway. This interaction of FAPα+ PSCs with pancreatic cancer cells may become a new strategy for the comprehensive treatment of pancreatic cancer.

[1]  T. Liang,et al.  The current surgical treatment of pancreatic cancer in China: a national wide cross-sectional study , 2019, Journal of Pancreatology.

[2]  Y. Yang,et al.  CLIC4 regulates TGF-β dependent myofibroblast differentiation to produce a cancer stroma , 2013, Oncogene.

[3]  V. Vinader,et al.  The emerging role of CXC chemokines and their receptors in cancer. , 2012, Future medicinal chemistry.

[4]  H. Friess,et al.  The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. , 2012, Current molecular medicine.

[5]  S. Dangi‐Garimella,et al.  Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice , 2012, Gut.

[6]  H. Friess,et al.  StellaTUM: current consensus and discussion on pancreatic stellate cell research , 2011, Gut.

[7]  Li Yang,et al.  Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. , 2011, Gastroenterology.

[8]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α , 2010, Science.

[9]  D. Mukhopadhyay,et al.  Pancreatic Stellate Cell Models for Transcriptional Studies of Desmoplasia-Associated Genes , 2010, Pancreatology.

[10]  G. Mills,et al.  CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis , 2010, Clinical Cancer Research.

[11]  V. O. Frick,et al.  Differential CXC Receptor Expression in Colorectal Carcinomas , 2008, Scandinavian journal of immunology.

[12]  J. Bernhagen,et al.  Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment , 2008, Proceedings of the National Academy of Sciences.

[13]  Mina J. Bissell,et al.  Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets , 2008, PloS one.

[14]  David Goldstein,et al.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells. , 2008, Cancer research.

[15]  Douglas B. Evans,et al.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.

[16]  J. Nesland,et al.  FAP-α and uPA Show Different Expression Patterns in Premalignant and Malignant Esophageal Lesions , 2008, Ultrastructural pathology.

[17]  D. V. Von Hoff,et al.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma , 2007, Molecular Cancer Therapeutics.

[18]  E. Ross,et al.  Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer , 2007, Clinical Cancer Research.

[19]  Yusuke Nakamura,et al.  EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth , 2006, Cancer science.

[20]  D. Notterman,et al.  GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1 , 2006, Clinical Cancer Research.

[21]  Andrew J. Wilson,et al.  EPHB4 and survival of colorectal cancer patients. , 2006, Cancer research.

[22]  M. Loeffler,et al.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.

[23]  R. Terkeltaub,et al.  Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. , 2006, The American journal of pathology.

[24]  E. Puré,et al.  Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. , 2006, Human pathology.

[25]  Yiling Lu,et al.  Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.

[26]  S. Pizzo,et al.  Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor, CD26. , 2005, Experimental cell research.

[27]  J S Wilson,et al.  Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells , 2004, Pancreas.

[28]  S. Ashley,et al.  Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. , 2004, Biochemical and biophysical research communications.

[29]  Takeshi Watanabe,et al.  PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism , 2004, Cancer Research.

[30]  W. Min,et al.  Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-induced Angiogenic Pathway* , 2003, Journal of Biological Chemistry.

[31]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[32]  K. Chayama,et al.  Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. , 2003, International journal of oncology.

[33]  C. Abbott,et al.  Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. , 2003, Biochemistry.

[34]  Roland L. Dunbrack,et al.  Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. , 2002, Cancer research.

[35]  K. Yokote,et al.  Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. , 2002, Biochemical and biophysical research communications.

[36]  Soumaya Bennouna,et al.  CXCR2 Deficiency Confers Impaired Neutrophil Recruitment and Increased Susceptibility During Toxoplasma gondii Infection1 , 2001, The Journal of Immunology.

[37]  S. Pizzo,et al.  Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. , 2001, The Biochemical journal.

[38]  N. Ohuchi,et al.  Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast , 2001, International journal of cancer.

[39]  Gordon L. Amidon,et al.  Targeted prodrug design to optimize drug delivery , 2000, AAPS PharmSci.

[40]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[41]  M. Korsten,et al.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture , 1998, Gut.

[42]  W. T. Chen,et al.  A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. , 1994, Cancer research.

[43]  J. Healey,et al.  Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Old,et al.  Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Burns,et al.  Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. , 2011, American journal of cancer research.

[46]  Wen‐Tien Chen,et al.  Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells , 2009, International journal of cancer.

[47]  A. Scott,et al.  Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients , 2004, Investigational New Drugs.

[48]  B. Karlan,et al.  Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. , 2003, Cancer research.

[49]  O. Götze,et al.  The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. , 1999, Blood.